Cargando…
Integrin Beta 5 Is a Prognostic Biomarker and Potential Therapeutic Target in Glioblastoma
Background: Glioblastoma (GBM) is the most lethal cancer of the central nervous system. Integrin beta 5 (ITGB5) is thought to be involved in intercellular signal transduction and regulation of tumor initiation and progression. However, the function of ITGB5 in GBM is not known. Methods: To address t...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764112/ https://www.ncbi.nlm.nih.gov/pubmed/31616629 http://dx.doi.org/10.3389/fonc.2019.00904 |